References
- Abraham NS. Proton pump inhibitors: Potential adverse effects. Curr Opin Gastroenterol 2012;28:615–620 (2012)
- Johnson DA, Oldfield EC. Reported side effects and complications of long-term proton pump inhibitor use: Dissecting the evidence. Clin Gastroenterol Hepatol 2013;11:458–464
- Rudelli A, Leduc I, Traulle C, Smail A, Ducroix JP, Andrejak M, Baillet J. Thrombopenia following treatment with omeprazole. Presse Med 1993;22:966
- Hayashibara T. Hemolytic anemia and thrombocytopenia associated with anti-omeprazole antibody. Rinsho Ketsueki 1998;39:447–452
- Zlabek JA, Anderson CG. Lansoprazole-induced thrombocytopenia. Ann Pharmacother 2002;36:809–811
- Watson TD, Stark JE, Vesta KS. Pantoprazole-induced thrombocytopenia. Ann Pharmacother 2006;40:758–761
- Miller JL, Gormley AK, Johnson PN. Pantoprazole-induced thrombocytopenia. Indian J Pediatr 2009;76:1278–1279
- Ranzino AM, Sorrells KR, Manor SM. Possible acute thrombocytopenia post esomeprazole and hydantoin coadministration. J Pharm Pract 2010;23:140–143
- Tas A. Thrombocytopenia as a side effect of pantoprazole. Turk J Gastroenterol 2013;24:295–296
- Korkmaz U, Alcelik A, Eroglu M, Korkmaz AN, Aktas G. Pantoprazole-induced thrombocytopenia in a patient with upper gastrointestinal bleeding. Blood Coagul Fibrinolysis 2013;24:352–353
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt J. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Therap 1981;30:239–245
- George JN, Raskob GE, Shah SR, Shah MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: A systematic review of published case reports. Ann Intern Med 1998;129:886–890
- Al-Nouri ZL, George JN. Drug-induced thrombocytopenia: An updated systematic review, 2012. Drug Saf 2012;35:693–694
- George N. Platelets on the web [Internet]. Drug-Induced Thrombocytopenia. 2013 July. Available from: http://www.ouhsc.edu/platelets/ditp.html [last accessed 25 May 2014]
- Reese JA, Li X, Hauben M, Aster R, Bougie D, Curtis BR, George JN, Vesely SK. Identifying drugs that cause acute thrombocytopenia: An analysis using 3 distinct methods. Blood 2010;116:2127–2133
- Arnold DM, Kukaswadia S, Nazi I, Esmail A, Dewar L, Smith JW, Warkentin TE, Kelton JG. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost 2013;11(1):169–176
- Dotan E, Katz R, Bratcher J, Wasserman C, Liebman M, Panagopoulos G, Spaccavento C. The prevalence of pantoprozole associated thrombocytopenia in a community hospital. Expert Opin Pharmacother 2007;8(13):2025–2028
- Binnetoglu E, Akbal E, Sen H, Gunes F, Erbag G, Asik M, Bozkurt N, Uludag A, Tekin M, Tekin SZ. Pantoprazole-induced thrombocytopenia in patients with upper gastrointestinal bleeding. Platelets 2014 . [Epub ahead of print]
- Visentin GP, Liu CY. Drug-induced thrombocytopenia. Hematol Oncol Clin North Am 2007;21:685–696
- Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: Pathogenesis, diagnosis, and management. J Thromb Haemost 2009;7:911–918
- Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev 2013;27:137–145
- Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580–587